Dr. Daniel Mark Van Handel, MD

Dr. Van Handel practices at Minneapolis Children's Surgery Center in Saint Paul, Minnesota.

Dr. Van Handel's NPI, 1093832453, was assigned on March 23, 2007. Dr. Van Handel graduated from University of Wisconsin School of Medicine in 2004. Dr. Van Handel holds Minnesota license 60000.

Dr. Van Handel's primary practice is Minneapolis Children's Surgery Center, at 1997 Sloan N Pl, Saint Paul, MN 55117 in Ramsey County. The practice phone is (651) 383-3333.

Dr. Van Handel's primary practice is Minneapolis Children's Surgery Center in Saint Paul, Minnesota. Dr. Van Handel is also affiliated with Abbott Northwestern Hospital. The medical group on file is MNGI Digestive Health. Dmand AI also links Dr. Van Handel to 4 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Handel practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Van Handel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Van Handel is licensed in Minnesota.

CMS data shows 5,641 Medicare services from Dr. Van Handel across 12 procedure codes in 2024, for 257 Medicare patients. Medicare paid $127,532 for them.

CMS counts 257 Medicare patients who saw Dr. Van Handel in 2024. The largest group is 65 to 74, with 136 patients. 63% of them have high blood pressure, and 62% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Handel's median patient age at 55, with 54% women.

In 2024, Dr. Van Handel wrote 532 Medicare Part D claims for 211 patients. 68% of them were for generic drugs. CMS names the drug for 389 of them, across 15 drugs with 11 or more claims each, at $1,360,549 in total drug cost. In 2023, CMS named 278 claims across 11 drugs.

Dr. Van Handel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Van Handel as offering telehealth. CMS counts 73 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Van Handel, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Van Handel, published from 2011 to 2025. Dr. Van Handel's most frequent co-authors are Paul E. Feuerstadt, MD, Sahil Khanna, MBBS and Teena Chopra, MD.

Dmand AI links Dr. Van Handel to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Crohn Disease, Inflammatory Bowel Diseases and Colitis, Ulcerative. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Van Handel that name 5 trials.

CMS Open Payments shows 45 general payments to Dr. Van Handel from 7 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 92% of the total. Ferring Pharmaceuticals Inc. paid the most, $37,908. It also lists 10 research payments totaling $14,739 from 2017 to 2021, naming 5 clinical trials.

Dr. Van Handel graduated from University of Wisconsin School of Medicine in 2004.